FREE CASE EVALUATION: CALL 1-800-632-1404
A testosterone lawsuit filed in the Louisiana Eastern District Court in March 2014 claims wrongful death of a man because of Low-T supplement side effects. The first-ever testosterone therapy lawsuit claiming death followed a spate of litigations and reports alleging a close link between testosterone replacement medications and heart attacks. With over $2 billion annual sales, testosterone replacement treatment has grown almost 200 times riding on aggressive direct-to-consumer marketing practices despite hundreds of post-marketing reports and research studies underlining fatal side effects in the recent years.
Sixty-one-year-old Louisiana resident John Peuler died of a heart attack in March last year. The victim had no history of cardiovascular disorders, diabetes, or strokes prior to using Testim gel, a Low-T supplement manufactured by Auxilium Pharmaceuticals and used as a treatment for boosting testosterone level in the blood. He experienced blood clots within a year of using the testosterone replacement therapy and died of sudden heart failure.
The testosterone wrongful death lawsuit filed by his family has alleged that the victim suffered unknowingly from heart attack risk and lost his life in the absence of any warning by the drug maker on the cardiovascular side effects of Testim gel. It describes the Low-T supplement as unsafe for consumers, unreasonably dangerous, and faulty product sold through aggressive and misleading promotional campaign by the manufacturer.
The latest wrongful death lawsuit joins the growing number of individual and class action testosterone lawsuits brought by consumers nationwide alleging fatal Low-T supplement side effects. AndroGel maker AbbVie is already named defendant in a dozens of testosterone therapy lawsuits while Pfizer, Actavis, and Watson pharmaceuticals are fighting similar litigations over AndroDerm patch and Depo-Testosterone Low-T injections.
Testosterone Therapy and Heart Attacks
In January 2014, the FDA ordered an investigation into the testosterone heart attack risk following more than 100 reports of such adverse events. Androgel, the most sold Low-T supplement, was alone blamed for 72 heart attacks, including 12 deaths. The federal regulator has also admitted to having received a large number reports on blood clotting events linked to testosterone replacement therapy.
“Low ‘T’: How to Sell Disease,” an article published by the American Medical Association journal in July 2013 flayed drug makers for aggressive and deceptive marketing practices “designed to convince men that they suffered from low testosterone” and use their Low-T supplements without proper medical examination for hypogonadism. The campaigns also concealed from public the potential testosterone replacement therapy side effects and played a role in increasing abuse of these medications, the report claimed.
The JAMA journal was the first to reveal the association between heart attack and testosterone replacement medications in a report published in 2013. Researchers claimed as much as 29 percent rise in the danger of potential heart attack in consumers using testosterone supplements. It triggered a spate of litigations and demand for more research on the safety of these medications.
A study involving 55,000 men and made public in January 2014 highlighted double risk of adverse heart disorders in those using Low-T drugs. Reported by the PLOSOne journal, it cited findings by California university researchers to claim at least 36 percent rise in the testosterone heart attack risk with increasing age as a greater threat.
If you or a loved one have experienced a testosterone replacement therapy injury after undergoing low testosterone therapy, please contact our team of lawyers today for a free case evaluation at:
CALL: 1-800-632-1404
FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.